Moderna announces positive data from phase 2 study of mrna vegf-a therapeutic in patients undergoing coronary artery bypass grafting surgery

Cambridge, mass.--(business wire)--moderna announces positive data from phase 2 study of mrna vegf-a therapeutic in patients undergoing coronary artery bypass grafting surgery
MRNA Ratings Summary
MRNA Quant Ranking